Dataset Information

Exploring use of unsupervised clustering to associate signaling profiles of GPCR ligands to clinical response.

ABSTRACT: Signaling diversity of G protein-coupled (GPCR) ligands provides novel opportunities to develop more effective, better-tolerated therapeutics. Taking advantage of these opportunities requires identifying which effectors should be specifically activated or avoided so as to promote desired clinical responses and avoid side effects. However, identifying signaling profiles that support desired clinical outcomes remains challenging. This study describes signaling diversity of mu opioid receptor (MOR) ligands in terms of logistic and operational parameters for ten different in vitro readouts. It then uses unsupervised clustering of curve parameters to: classify MOR ligands according to similarities in type and magnitude of response, associate resulting ligand categories with frequency of undesired events reported to the pharmacovigilance program of the Food and Drug Administration and associate signals to side effects. The ability of the classification method to associate specific in vitro signaling profiles to clinically relevant responses was corroborated using β2-adrenergic receptor ligands.

SUBMITTER: Benredjem B

PROVIDER: S-EPMC6733853 | biostudies-literature | 2019 Sep

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Exploring use of unsupervised clustering to associate signaling profiles of GPCR ligands to clinical response.

Benredjem Besma B Gallion Jonathan J Pelletier Dennis D Dallaire Paul P Charbonneau Johanie J Cawkill Darren D Nagi Karim K Gosink Mark M Lukasheva Viktoryia V Jenkinson Stephen S Ren Yong Y Somps Christopher C Murat Brigitte B Van Der Westhuizen Emma E Le Gouill Christian C Lichtarge Olivier O Schmidt Anne A Bouvier Michel M Pineyro Graciela G

Nature communications 20190909 1

Signaling diversity of G protein-coupled (GPCR) ligands provides novel opportunities to develop more effective, better-tolerated therapeutics. Taking advantage of these opportunities requires identifying which effectors should be specifically activated or avoided so as to promote desired clinical responses and avoid side effects. However, identifying signaling profiles that support desired clinical outcomes remains challenging. This study describes signaling diversity of mu opioid receptor (MOR) ...[more]

PMID: 31501422

Similar Datasets

Project description:MotivationG protein-coupled receptors (GPCRs) can selectively bind to many types of ligands, ranging from light-sensitive compounds, ions, hormones, pheromones and neurotransmitters, modulating cell physiology. Considering their role in many essential cellular processes, they are one of the most targeted protein families, with over a third of all approved drugs modulating GPCR signalling. Despite this, the large diversity of receptors and their multipass transmembrane architectures make the identification and development of novel specific, and safe GPCR ligands a challenge. While computational approaches have the potential to assist GPCR drug development, they have presented limited performance and generalization capabilities. Here, we explored the use of graph-based signatures to develop pdCSM-GPCR, a method capable of rapidly and accurately screening potential GPCR ligands.ResultsBioactivity data (IC50, EC50, Ki and Kd) for individual GPCRs were curated. After curation, we used the data for developing predictive models for 36 major GPCR targets, across 4 classes (A, B, C and F). Our models compose the most comprehensive computational resource for GPCR bioactivity prediction to date. Across stratified 10-fold cross-validation and blind tests, our approach achieved Pearson's correlations of up to 0.89, significantly outperforming previous methods. Interpreting our results, we identified common important features of potent GPCRs ligands, which tend to have bicyclic rings, leading to higher levels of aromaticity. We believe pdCSM-GPCR will be an invaluable tool to assist screening efforts, enriching compound libraries and ranking candidates for further experimental validation.Availability and implementationpdCSM-GPCR predictive models and datasets used have been made available via a freely accessible and easy-to-use web server at http://biosig.unimelb.edu.au/pdcsm_gpcr/.Supplementary informationSupplementary data are available at Bioinformatics Advances online.

Dataset Information

Exploring use of unsupervised clustering to associate signaling profiles of GPCR ligands to clinical response.

Publications

Exploring use of unsupervised clustering to associate signaling profiles of GPCR ligands to clinical response.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets